Could a probiotic soothe PTSD? new study tests Gut-Brain link in veterans
NCT ID NCT04150380
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a probiotic called Lactobacillus rhamnosus GG can reduce inflammation and PTSD symptoms in veterans. Researchers enrolled 383 veterans with PTSD and gut issues, giving them either the probiotic or a placebo. The goal was to see if calming inflammation in the body could also ease PTSD symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Lactobacillus rhamnosus GG (a probiotic)
- What this could lead to
- If it works, this could point toward a simple, natural supplement to help ease PTSD symptoms and related inflammation in veterans.
- What could go wrong
- This is a Phase 2 trial, so results are still early. The probiotic may not significantly improve symptoms, and benefits may not apply to non-veterans or those without gut issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
383 people
The number who actually took part.
- Started
-
Aug 2020
- Finished
-
Dec 2025
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria * History of at least one deployment in support of OEF/OIF * Current diagnosis of PTSD per the Clinician Administered PTSD Scale-5 (CAPS-5) * Current diagnosis of Functional Bowel Disorder by ROME IV * CRP level of 1.0 mg/L or above at baseline * Medical clearance to participate by study providers * Age between 18 and 60 * Ability to provide informed consent * Willingness to abstain from probiotic supplements (pills, tablets, oils, foods, etc.) other than the investigational product provided until all study procedures are completed * Willingness to provide blood and stool samples Exclusion criteria * Inability to adequately respond to questions regarding the informed consent procedure * Currently involved in the criminal justice system as a prisoner or ward of the state * Non-English speaking * Current (past month) alcohol or substance abuse or dependence * Lifetime history of bipolar disorder or psychosis or anxiety disorders (excluding PTSD). * Consistent (e.g., 5x/week or greater) probiotic supplementation within the last month, including probiotic food products such as yogurt, as determined by phone screen interview and Probiotic Food Check List * Receiving intravenous, intramuscular, or oral antibiotics within the last month * Presence of central venous catheters (CVCs) * Gastrointestinal (GI) barriers as identified by the 2-week run-in period as determined by the study team * Participation in conflicting interventional research protocol * Vital signs outside of acceptable range, i.e., blood pressure \>160/100, pulse \>100 * Use of any of the following drugs within the last 6 months: antifungals, antivirals or antiparasitics (intravenous, intramuscular, or oral); oral, intravenous, intramuscular, or inhaled corticosteroids; cytokines or cytokine inhibitors; methotrexate or immunosuppressive cytotoxic agents * Acute disease at the time of enrollment (defer sampling until the participant recovers). Acute disease is defined as the presence of a moderate or severe illness with or without fever (e.g., oral temperature \>100° F) * Any medical condition deemed exclusionary by the Principal Investigators * History of cancer * Unstable dietary history as determined by the PIs (e.g., major changes in diet during the previous month, where the subject has eliminated or significantly increased a major food group in the diet) * Positive test for human immunodeficiency virus (HIV), Hepatitis B virus, or Hepatitis C virus * Any confirmed or suspected condition/state of immunosuppression or immunodeficiency (primary or acquired) including HIV infection, or those receiving immunosuppressive drugs or treatment including antineoplastic therapy, post-transplantation immunosuppressive therapy, and/or radiation therapy * Major surgery of the GI tract, with the exception of cholecystectomy and appendectomy, in the past five years. Any major bowel resection at any time * Female who is pregnant or lactating * Treatment for or suspicion of ever having had toxic shock syndrome * History of moderate and/or severe traumatic brain injury
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Functional bowel disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
VA Rocky Mountain Regional Center
Denver, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five sessions to quiet trauma nightmares in bipolar disorder
- Can a berry extract help athletes bounce back after brutal workouts?
- Can PET scans reveal hidden heart inflammation after a stroke?
- After a stroke, does the heart inflame? MRI study probes the link
- 150,000 children to be tracked from birth to old age in massive health study
- Can training hospital staff in Trauma-Informed care make childbirth safer?